Objective: To explore the effect of composite salvia injection combined with ulnastatin in treatments of acute pancreatitis. Method: One hundred and sixteen cases with acute pancreatitis were randomly divided into control group and experience group. Control group was given routine treatment and ulinastatin quiescent point. Experience group received composite salvia injection combined with ulinastatin therapy. Clinical efficacy

laboratory indexes and inflammatory factors were compared between two groups. Result: The effective rates of treatment in experience group were much higher than that in control group(93.3% vs 80.4%

P<0.05). Hospital stay in experience group was much less than that in control group (P<0.05); comparison with control group

blood amylase

leukocyte

interleukin-6(IL-6) and tumor necrosis factor-α(TNF-α) after treatment in experience group greatly decreased (P<0.05). Conclusion: Composite salvia injection combined with ulinastatin for acute pancreatitis greatly decrease the serum inflammatory factors and improve the clinical efficacy.